только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 12 / 13
Страница 4 / 4

Список литературы к главе 11

Внимание! Часть функций, например, копирование текста к себе в конспект, озвучивание и т.д. могут быть доступны только в режиме постраничного просмотра.Режим постраничного просмотра
 
 

48. Oliver M.H., Harding J.E., Breier B.H., Evans P.C., Gluckman P.D. Glucose but not a mixed amino acid infusion regulates plasma insulin-like growth factor-I concentrations in fetal sheep // Pediatr. Res. 1993. Vol. 34, N 1. P. 62–65. DOI: 10.1203/00006450-199307000-00015.

49. Han V.K.M., Fowden A. Paracrine regulation of fetal growth // ed. by R.H.T. Ward, S.K. Smith, D. Donnai. Early fetal growth and development. London: RCOG Press; 1994. P. 275–291.

50. Stephens E., Thureen P.J., Goalstone M.L., Anderson M.S., Leitner J.W., Hay W.W. et al. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues // Am. J. Physiol. Metab. [Internet]. 2001. Vol. 281, N 2. P. E217–E223. DOI: 10.1152/ajpendo.2001.281.2.E217.

51. Kennaugh J.M., Bell A.W., Teng C., Meschia G., Battaglia F.C. Ontogenetic changes in the rates of protein synthesis and leucine oxidation during fetal life // Pediatr. Res. 1987. Vol. 22, N 6. P. 688–692. DOI: 10.1203/00006450-198712000-00015.

52. Wilkening R.B., Boyle D.W., Teng C., Meschia G., Battaglia F.C. Amino acid uptake by the fetal ovine hindlimb under normal and euglycemic hyperinsulinemic states // Am. J. Physiol. Metab. 1994. Vol. 266, N 1. P. E72–E78. DOI: 10.1152/ajpendo.1994.266.1.E72.

53. Magnusson-Olsson A.L., Hamark B., Ericsson A., Wennergren M., Jansson T., Powell T.L. Gestational and hormonal regulation of human placental lipoprotein lipase // J. Lipid. Res. 2006. Vol. 47, N 11. P. 2551–2561. DOI: 10.1194/jlr.M600098-JLR200.

54. Magnusson A.L., Waterman I.J., Wennergren M., Jansson T., Powell T.L. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes // J. Clin. Endocrinol. Metab. [Internet]. 2004. Vol. 89, N 9. P. 4607–4614. DOI: 10.1210/jc.2003-032234.

55. Starikov R.S., Inman K., Has P., Iqbal S.N., Coviello E., He M. Correlation of placental pathology and perinatal outcomes with Hemoglobin A1c in early pregnancy in gravidas with pregestational diabetes mellitus // Placenta. 2017. Vol. 52. P. 94–99. DOI: 10.1016/j.placenta.2017.02.024.

56. International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation, 2019.

57. Khong T.Y., Mooney E.E., Ariel I., Balmus N.C., Boyd T.K., Brundler M.A. et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement // Arch. Pathol. Lab. Med. 2016. Vol. 140, N 7. P. 698–713. DOI: 10.5858/arpa.2015-0225-CC.

58. Blackburn S. Maternal, fetal & neonatal physiology. 4th ed. Saunders; Maryland Heights, 2013. P. 79–85.

59. Cuffe J.S.M., Holland O., Salomon C., Rice G.E., Perkins A.V. Review: placental derived biomarkers of pregnancy disorders // Placenta. 2017. Vol. 54. P. 104–110. DOI: 10.1016/j.placenta.2017.01.119.

60. Schoots M.H., Gordijn S.J., Scherjon S.A., van Goor H., Hillebrands J.L. Oxidative stress in placental pathology // Placenta. 2018. Vol. 69. P. 153–161. DOI: 10.1016/j.placenta.2018.03.003.

61. American Diabetes Association. Standards of medical care in diabetes — 2014 // Diabetes Care. 2014. Vol. 37. Suppl. 1. P. S14–S80. DOI: 10.2337/dc14-S014.

62. Hahn T., Barth S., Weiss U., Mosgoeller W., Desoye G. Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development? // FASEB J. 1998. Vol. 12, N 12. P. 1221–1231. DOI: 10.1096/fasebj.12.12.1221.

63. Osmond D.T., Nolan C.J., King R.G., Brennecke S.P., Gude N.M. Effects of gestational diabetes on human placental glucose uptake, transfer, and utilisation // Diabetologia. 2000. Vol. 43, N 5. P. 576–582. DOI: 10.1007/s001250051346.

64. Cetin I., de Santis M.S., Taricco E., Radaelli T., Teng C., Ronzoni S. et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus // Am. J. Obstet. Gynecol. 2005. Vol. 192, N 2. P. 610–617. DOI: 10.1016/j.ajog.2004.08.011.

65. Капустин Р.В., Оноприйчук А.Р., Аржанова О.Н. и др. Патофизиология плаценты и плода при сахарном диабете // Журнал акушерства и женских болезней. 2018. № 6. С. 79–92.

66. Huynh J., Dawson D., Roberts D., Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus // Placenta. 2015. Vol. 36, N 2. P. 101–114. DOI: 10.1016/j.placenta.2014.11.021.

67. Roescher A.M., Hitzert M.M., Timmer A., Verhagen E.A., Erwich J.J., Bos A.F. Placental pathology is associated with illness severity in preterm infants in the first twenty-four hours after birth // Early Hum. Dev. 2011. Vol. 87, N 4. P. 315–319. DOI: 10.1016/j.earlhumdev.2011.01.040.

68. Taricco E., Radaelli T., Nobile de Santis M.S., Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes // Placenta. 2003. Vol. 24, N 4. P. 343–347. DOI: 10.1053/plac.2002.0913.

69. Evers I.M., Nikkels P.G., Sikkema J.M., Visser G.H. Placental pathology in women with type 1 diabetes and in a control group with normal and large-for-gestational-age infants // Placenta. 2003. Vol. 24, N 8–9. P. 819–825. DOI: 10.1016/s0143-4004(03)00128-0.

70. Траль Т.Г., Толибова Г.Х., Мусина Е.В. и др. Молекулярно-морфологические особенности формирования хронической плацентарной недостаточности, обусловленной разными типами сахарного диабета (обзор) // Сахарный диабет. 2020. Т. 23, № 2. С. 185–191.

71. Desoye G., Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network // Diabetes Care. 2007. Vol. 30. Suppl. 2. P. S120-S126. DOI: 10.2337/dc07-s203.

72. Huynh J., Yamada J., Beauharnais C., Wenger J.B., Thadhani R.I., Wexler D. et al. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion // Placenta. 2015. Vol. 36, N 10. P. 1161–1166. DOI: 10.1016/j.placenta.2015.08.004.

73. Daskalakis G., Marinopoulos S., Krielesi V., Papapanagiotou A., Papantoniou N., Mesogitis S., Antsaklis A. Placental pathology in women with gestational diabetes // Acta. Obstet. Gynecol. Scand. 2008. Vol. 87, N 4. P. 403–407. DOI: 10.1080/00016340801908783.

74. Madazli R., Tuten A., Calay Z., Uzun H., Uludag S., Ocak V. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls // Gynecol. Obstet. Invest. 2008. Vol. 65, N 4. P. 227–232. DOI: 10.1159/000113045.

75. Higgins M.F., Russell N.M., Mooney E.E., McAuliffe F.M. Clinical and ultrasound features of placental maturation in pre-gestational diabetic pregnancy // Early Hum. Dev. 2012. Vol. 88, N 10. P. 817–821. DOI: 10.1016/j.earlhumdev.2012.06.001.

76. Tennant P.W., Glinianaia S.V., Bilous R.W., Rankin J., Bell R. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study // Diabetologia. 2014. Vol. 57, N 2. P. 285–294. DOI: 10.1007/s00125-013-3108-5.

77. Leach L., Taylor A., Sciota F. Vascular dysfunction in the diabetic placenta: causes and consequences // J. Anat. 2009. Vol. 215, N 1. P. 69–76. DOI: 10.1111/j.1469-7580.2009.01098.x.

78. Mayhew T.M. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells // Placenta. 2002. Vol. 23, N 10. P. 742–750. DOI: 10.1016/s0143-4004(02)90865-9.

79. Mayhew T.M. Enhanced fetoplacental angiogenesis in pre-gestational diabetes mellitus: the extra growth is exclusively longitudinal and not accompanied by microvascular remodelling // Diabetologia. 2002. Vol. 45, N 10. P. 1434–1439. DOI: 10.1007/s00125-002-0927-1.

80. Jirkovská M., Janácek J., Kaláb J., Kubínová L. Three-dimensional arrangement of the capillary bed and its relationship to microrheology in the terminal villi of normal term placenta // Placenta. 2008. Vol. 29, N 10. P. 892–897. DOI: 10.1016/j.placenta.2008.07.004.

81. Shams F., Rafique M., Samoo N.A., Irfan R. Fibrinoid necrosis and hyalinization observed in normal, diabetic and hypertensive placentae // J. Coll. Physicians Surg. Pak. 2012. Vol. 22, N 12. P. 769–772.

82. Beauharnais C.C., Roberts D.J., Wexler D.J. High rate of placental infarcts in type 2 compared with type 1 diabetes // J. Clin. Endocrinol. Metab. 2012. Vol. 97, N 7. P. E1160–E1164. DOI: 10.1210/jc.2011-3326.

83. Rudge M.V., Lima C.P., Damasceno D.C., Sinzato Y.K., Napoli G., Rudge C.V. et al. Histopathological placental lesions in mild gestational hyperglycemic and diabetic women // Diabetol. Metab. Syndr. 2011. Vol. 3, N 1. P. 19. DOI: 10.1186/1758-5996-3-19.

84. al-Okail M.S., al-Attas O.S. Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients // Endocr. J. 1994. Vol. 41, N 4. P. 355–360.

85. Younes B., Baez-Giangreco A., al-Nuaim L., al-Hakeem A., Abu Talib Z. Basement membrane thickening in the placentae from diabetic women // Pathol. Int. 1996. Vol. 46, N 2. P. 100–104. DOI: 10.1111/j.1440-1827.1996.tb03585.x.

86. Negrato C.A., Mattar R., Gomes M.B. Adverse pregnancy outcomes in women with diabetes // Diabetol Metab. Syndr. 2012. Vol. 4, N 1. P. 41. DOI: 10.1186/1758-5996-4-41.

87. Calderon I.M., Damasceno D.C., Amorin R.L., Costa R.A., Brasil M.A., Rudge M.V. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes // Diabetes Res. Clin. Pract. 2007. Vol. 78, N 1. P. 65–71. DOI: 10.1016/j.diabres.2007.01.023.

88. Айламазян Э.К., Абашова Е.И., Аржанова О.Н. и др. Сахарный диабет и репродуктивная система женщины: руководство для врачей. Москва: ГЭОТАР-Медиа, 2019. 432 с.

89. Predoi C.G., Grigoriu C., Vladescu R., Mihart A.E. Placental damages in preeclampsia — from ultrasound images to histopathological findings // J. Med. Life. 2015. 8 Spec Issue (Spec Issue). P. 62–65.

90. Vinnars M.T., Nasiell J., Ghazi S., Westgren M., Papadogiannakis N. The severity of clinical manifestations in preeclampsia correlates with the amount of placental infarction // Acta Obstet. Gynecol. Scand. 2011. Vol. 90, N 1. P. 19–25. DOI: 10.1111/j.1600-0412.2010.01012.x.

91. Zigić Z., Marković S., Grbesa D., Ramić S., Halilović A. Quantitative research of capillaries in terminal villi of mature placentae // Bosn. J. Basic Med. Sci. 2010. Vol. 10, N 2. P. 147–152. DOI: 10.17305/bjbms.2010.2714.

92. Fitzgerald B., Shannon P., Kingdom J., Keating S. Rounded intraplacental haematomas due to decidual vasculopathy have a distinctive morphology // J. Clin. Pathol. 2011. Vol. 64, N 8. P. 729–732. DOI: 10.1136/jcp.2010.087916.

93. Burton G.J., Jauniaux E., Charnock-Jones D.S. The influence of the intrauterine environment on human placental development // Int. J. Dev. Biol. 2010. Vol. 54. P. 303–312. DOI: 10.1387/ijdb.082764gb.